Racquel Bracken

General Partner

2016

Investing broadly in private healthcare companies with an interest in biotech

Board Member

2024

Board Member

2021

Discovering and developing novel antibody drug conjugate antibody therapies in oncology

Board Member, Treasurer

2019

Essential Access Health (formerly California Family Health Council) is a non-profit organization that champions and promotes quality sexual and reproductive health care for all. Essential Access Health achieves its mission through an umbrella of services including advanced clinical research, provider training, patient education and consumer awareness, public policy and clinic support initiatives. As the administrator of the nation's largest Title X federal family planning program, we partner with a diverse provider network that collectively serves nearly one million women, men and teens annually at more than 340 health centers in 37 of California's 58 counties.

Acting Chief Executive Officer

2022 - 2024

Confluence Therapeutics is pioneering a novel platform of RNA binding protein targeted oligonucleotide therapeutics for therapeutic areas with significant unmet need.

Board Member

2017 - 2023

CEO and co-founder

2018 - 2020

Microbial cell therapy for diseases with high unmet medical need

Marketing Director

2015 - 2016

Responsible for leading the marketing team for rucaparib, a PARP inhibitor for the treatment of advanced ovarian cancer. Rucaparib received breakthrough therapy designation from the FDA in 2015 and NDA filing is expected mid-2016.

Head of Business Development

2009 - 2016

Responsible for the in-licensing of the current Clovis pipeline, including: global rights to rociletinib (CO-1686) from Avila Therapeutics (now Celgene), rucaparib (CO-338) from Pfizer, and US and Japanese right to lucitanib from EOS.

Associate

2006 - 2009

Analyst

2005 - 2006